Literature DB >> 20651940

Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.

Stacey L Hembruff1, Nikki Cheng.   

Abstract

Chemokines are soluble factors shown to play important roles in regulating immune cell recruitment during inflammatory responses and defense against foreign pathogens. De-regulated expression and activity of several chemokine signaling pathways have been implicated in cancer progression, including: CCL2, CCL5, CXCL1 and CXCL12. While studies in the past have focused the role of these chemokine signaling pathways in regulating immune responses, emerging studies show that these molecules regulate diverse cellular processes including angiogenesis, and regulation of epithelial cell growth and survival. New evidence indicates that chemokines are critical for cancer progression and indicate complex and diverse functions in the tumor microenvironment. This review will focus on the contributions of chemokine signaling in regulating cancer microvironment and discuss the utility of targeting or delivering chemokines in cancer therapeutics.

Entities:  

Year:  2009        PMID: 20651940      PMCID: PMC2907742     

Source DB:  PubMed          Journal:  Cancer Ther


  109 in total

Review 1.  Multiple chemotactic factors: fine control or redundancy?

Authors:  M N Devalaraja; A Richmond
Journal:  Trends Pharmacol Sci       Date:  1999-04       Impact factor: 14.819

Review 2.  Regulation of chemotactic networks by 'atypical' receptors.

Authors:  Iain Comerford; Wendel Litchfield; Yuka Harata-Lee; Robert J B Nibbs; Shaun R McColl
Journal:  Bioessays       Date:  2007-03       Impact factor: 4.345

3.  The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2.

Authors:  H J M A A Zijlmans; G J Fleuren; H J Baelde; P H C Eilers; G G Kenter; A Gorter
Journal:  J Pathol       Date:  2006-03       Impact factor: 7.996

4.  Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.

Authors:  Alejandro Vazquez-Martin; Ramon Colomer; Javier A Menendez
Journal:  Eur J Cancer       Date:  2007-03-26       Impact factor: 9.162

5.  Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.

Authors:  Shusaku Ohira; Motoko Sasaki; Kenichi Harada; Yasunori Sato; Yoh Zen; Kumiko Isse; Kazuto Kozaka; Akira Ishikawa; Koji Oda; Yuji Nimura; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

6.  CXCR4 regulates growth of both primary and metastatic breast cancer.

Authors:  Matthew C P Smith; Kathryn E Luker; Joel R Garbow; Julie L Prior; Erin Jackson; David Piwnica-Worms; Gary D Luker
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

Review 7.  Chemokines in idiopathic inflammatory myopathies.

Authors:  Boel De Paepe; Kim K Creus; Jan L De Bleecker
Journal:  Front Biosci       Date:  2008-01-01

8.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

9.  A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.

Authors:  Srinivasan Madhusudan; Martin Foster; Sethupathi R Muthuramalingam; Jeremy P Braybrooke; Susan Wilner; Kulwinder Kaur; Cheng Han; Susan Hoare; Frances Balkwill; Denis C Talbot; Trivadi S Ganesan; Adrian L Harris
Journal:  Clin Cancer Res       Date:  2004-10-01       Impact factor: 12.531

10.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

View more
  33 in total

1.  Knockdown of FOXP1 promotes the development of lung adenocarcinoma.

Authors:  Hua Sheng; Xiangyang Li; Yi Xu
Journal:  Cancer Biol Ther       Date:  2018-11-08       Impact factor: 4.742

2.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

3.  A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways.

Authors:  Junwei Han; Chunquan Li; Haixiu Yang; Yanjun Xu; Chunlong Zhang; Jiquan Ma; Xinrui Shi; Wei Liu; Desi Shang; Qianlan Yao; Yunpeng Zhang; Fei Su; Li Feng; Xia Li
Journal:  J R Soc Interface       Date:  2015-01-06       Impact factor: 4.118

4.  Virus proteins similar to human proteins as possible disturbance on human pathways.

Authors:  Zhao Jin; Masaaki Kotera; Susumu Goto
Journal:  Syst Synth Biol       Date:  2014-05-24

5.  Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs.

Authors:  E C Halvorsen; M J Hamilton; A Young; B J Wadsworth; N E LePard; H N Lee; N Firmino; J L Collier; K L Bennewith
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

6.  Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.

Authors:  Wei Bin Fang; Iman Jokar; Anna Chytil; Harold L Moses; Ty Abel; Nikki Cheng
Journal:  Clin Exp Metastasis       Date:  2011-03-04       Impact factor: 5.150

7.  Chemokine binding protein vCCI attenuates vaccinia virus without affecting the cellular response elicited by immunization with a recombinant vaccinia vector carrying the HPV16 E7 gene.

Authors:  Pavel Gabriel; Katarina Babiarova; Kamila Zurkova; Jitka Krystofova; Petr Hainz; Luda Kutinova; Sarka Nemeckova
Journal:  Viral Immunol       Date:  2012-10       Impact factor: 2.257

8.  Trp53 inactivation in the tumor microenvironment promotes tumor progression by expanding the immunosuppressive lymphoid-like stromal network.

Authors:  Gang Guo; Luis Marrero; Paulo Rodriguez; Luis Del Valle; Augusto Ochoa; Yan Cui
Journal:  Cancer Res       Date:  2013-01-14       Impact factor: 12.701

9.  CXCL3 Signaling in the Tumor Microenvironment.

Authors:  Niradiz Reyes; Stephanie Figueroa; Raj Tiwari; Jan Geliebter
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.

Authors:  Muthulekha Swamydas; Krista Ricci; Stephen L Rego; Didier Dréau
Journal:  Cell Adh Migr       Date:  2013-05-24       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.